Zurich-Schlieren, Switzerland, 7 September 2023
We are thrilled to announce that TOPADUR Pharma AG has once again been recognized as one of Switzerland's top 25 scale-up companies.
This achievement is a demonstration to our team's dedication and our partners' support.
We are grateful for this recognition and remain committed to pushing the boundaries of innovation in the years to come.
Please check out the link below.
Topadur Pharma AG and Juvic Inc. Launch Transnational Collaboration for the Disease Management of Systemic Sclerosis
Read moreTOPADUR Pharma AG announces dosing of first healthy subjects in Phase 1 clinical trial of TOP-N53.
Read moreTOPADUR announced that Pascal Brenneisen has been appointed CEO, effective April 1, 2023, on top of his Board member assignment.
Read more